We’re #hiring for a Customer Service Representative & Office Administrator to join us in our South San Francisco office. Know someone who might be interested? Apply today or share this post with your network.
Spirair
Medical Equipment Manufacturing
South San Francisco, CA 1,486 followers
Pioneering minimally invasive therapies for ENTs to help more patients breathe better
About us
Spirair is an early-stage company pioneering minimally invasive solutions that help ENTs advance care for their patients by providing strong outcomes and a better patient experience. We’re committed to developing new therapies that can easily integrate in any ENT’s treatment algorithms so they can help more of their patients breathe better. Spirair got its start in the Stanford Biodesign Innovation Fellowship, a program that equips aspiring innovators with a proven, repeatable process to identify important health-related needs, invent novel health technologies to address them, and prepare to implement those products into patient care. Founders James Kintzing, Ph.D. and Brandon McCutcheon, M.D. were co-fellows in the program and identified an opportunity in the ENT space when they discovered the unmet need for a minimally invasive nasal septal deviation correction therapy to help address nasal airway obstruction. Our first product is a novel solution for symptomatic nasal septal deviation (NSD) that supports and straightens minor deviations in the septal cartilage. The procedure can be conveniently and safely performed under local anesthesia in any site of service as part of standard septoplasty techniques.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
South San Francisco, CA, US
Employees at Spirair
Updates
-
We’re #hiring for a Quality Engineer to join us. Know someone who might be interested? Apply today or share this post with your network.
-
💡 Sometimes, #innovation begins with reimagining the familiar: https://lnkd.in/e3VjSUjT This is what Spirair co-founders James Kintzing, Ph.D and Brandon McCutcheon, M.D. learned as they began developing SeptAlign, the first and only minimally invasive therapy for mechanical correction of nasal #SeptalDeviation. They shared more about this journey – from identifying the unmet need, to selecting SeptAlign’s implant material, to bringing the therapy to market – with Medical Design & Outsourcing. 👆 Check out their contributed article to learn more. #ENT #Otolaryngology #NasalObstruction #DeviatedSeptum #MedTech
-
-
👀 #ICYMI: SeptAlign™ is now FDA cleared: https://lnkd.in/g3F_kG6w SeptAlign is a minimally invasive, massively impactful therapy that expands #ENT toolkits to treat minor nasal #SeptalDeviation and help address nasal airway obstruction (NAO). #FDAnews #DeviatedSeptum #NasalObstruction #Otolaryngology #MedTech
-